Argenica Therapeutics Ltd (AU:AGN) has released an update.
Argenica Therapeutics Limited (ASX: AGN) has requested a trading halt on its securities pending an announcement related to a capital raising initiative. The halt will be in effect until the start of normal trading on April 12, 2024, or when the company makes its capital raising announcement, whichever comes first. This strategic move is aimed at managing market activities before the anticipated news about the company’s financial maneuver.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.
